We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Anne Lynn Chang

Anne Lynn S Chang MD

Associate Professor of Dermatology, Stanford University School of Medicine, Stanford, California, USA
Dr. Anne Lynn S. Chang is an Associate Professor of Dermatology at the Stanford University School of Medicine whose research focuses on cutaneous oncology, aging and geriatric dermatology. Her studies have helped to bring three cutaneous oncology drugs to FDA approval, including two that were first-in-class, one for advanced basal cell carcinoma and one for advanced squamous cell carcinoma. She is working to better understand why some patients respond to therapy and others do not. Dr. Chang’s clinical practice is located at the Stanford Cancer Institute


Clinical investigator and advisory board member for Regeneron, Genentech-Roche, and Merck.